stella
beta
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants — Stella
Recruiting
Back to Healthy trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
New Zealand
Clinical Research Unit, Christchurch
View full record on ClinicalTrials.gov